Location: Home
  • search
  • go
  • Relate News
  • 7/12/2012HIT Global to Offer CME Programs in China through JV
  • 7/12/2012Latest IMS Study Predicts Rebound in Global Medicine Spending to US$1....
  • 7/12/2012Swiss CMO Siegfried to Build a New API Facility in China
  • 7/12/2012Alnylam and Ascletis Form Strategic Collaboration to Develop RNAi Live...
  • 7/11/2012Chinese VC Producers Denies Price Fixing in US Lawsuit as Court Date S...
  • 7/11/2012IMS Health: China Pharmaceutical Market Snapshot in Q1/2012
  • 7/11/2012Private Money Pours Into China's Healthcare, Boosting Fortune For Cimi...
  • 7/11/2012BMI Releases Forecast for the Third Quarter of This Year
  • 7/10/2012Recent Executive Moves
  • 7/10/2012New Boss of Shanghai Pharma Speculated
  • 7/9/2012Walvax Acquires Majority Control of Shanghai Fengmao Biotech for Entry...
  • 7/9/2012China Increases Its Activity in Regulated Markets
  • 7/6/2012ShangPharma Chairman Offers to Take the Company Private
  • 7/6/2012Analysts Expects Renewed Pharma Industry Growth in the Second Half
  • 7/4/2012BMS Acquires Amylin as GSK Extends Offer for Human Genome Sciences
  • 7/4/2012Beike Biotech Reports Effectiveness of Stem Cell Treatment for PBC
  • 7/4/2012Emerging Lessons from the Emerging Markets (External)
  • 7/4/2012Pfizer and Hisoar Enter into 20-Year Supply Agreement for Clindamycin
  • 7/4/2012Pharma Gets Social: China - Pharma's Social Media Frontier (External)
  • 7/4/2012Recent Executive Moves
  • 7/3/2012Pharma Industry Performance Up Considerably in the First Five Months
  • 7/2/2012MOHRSS Releases 2011 Statistics for HR and Social Security Development
  • 7/2/2012SFDA Seeks Comments on Draft Rule on Risk Assessment for Onsite Inspec...
  • 7/2/2012CMOs and Final Dosage Manufacturing in China (External)
  • 6/29/2012Chinese Government to Fund New Drug Innovation with CNY 115B by 2020
  • 6/29/2012Recent Executive Moves
  • 6/28/2012Nanjing Pharma and Alliance Boots Extends Expiration Date of LOI
  • 6/28/2012Schizophrenia Prevalence Highlighted at XiAn Janssen's Invega Sustenna...
  • 6/28/2012NAOC: Drug Sales Margins at County Level Hospital Far Exceed 15%
  • 6/27/2012Use of Biologic Agents Bottlenecked in China by Under-reimbursement
  • Page:286/367 Total number of articles:10986: [First][<<] [284] [285] [286] [287] [288] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group